We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DB1:XETRDeutsche Boerse AG Analysis

Data as of 2026-05-24 - not real-time

€256.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Deutsche Börse AG (DB1.DE) is trading at €256, comfortably above its 20‑day (≈€255.15) and 50‑day (≈€252.52) simple moving averages and the 200‑day SMA (≈€232.66), confirming a bullish trend. The MACD histogram is positive (≈0.29) and the MACD line sits above the signal line, while the RSI sits at a neutral 53, indicating room for further upside without immediate overbought pressure. Fundamentals remain robust with an 8.5% revenue growth, operating margins above 40%, and a solid ROE of ~19%, though the trailing PE of ~22.8 is notably higher than the industry average of ~16.8, suggesting a premium valuation. The dividend yield of 1.64% is backed by a modest payout ratio of ~36%, supporting sustainability.
Market sentiment is extremely bullish (Fear‑Greed Index 91.6) and analysts collectively rate the stock as a “buy” with a median target of €293, implying ~12% upside. The recent listing of the Virtune Hyperliquid ETP on Xetra adds a new crypto‑asset revenue stream, reinforcing the exchange’s diversification and growth narrative.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup (price above SMA20/50, positive MACD)
  • Neutral RSI indicating upside potential
  • Positive crypto‑asset listing expanding revenue sources

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings growth and high operating margins
  • Target price upside of ~12% and favorable analyst consensus
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable cash flow generation and solid ROE
  • Premium valuation relative to peers requiring careful monitoring
  • Regulatory environment and diversification into digital assets

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin27.26%
P/E Ratio22.8
ROE19.20%
ROA0.65%
Debt/Equity65.44
P/B Ratio4.4
Industry P/E16.8

Technical Analysis

TrendBullish
RSI53.4
Support€240.80
Resistance€269.60
MA 20€255.15
MA 50€252.52
MA 200€232.66
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Target Price€287.92
Upside/Downside12.47%
GradeFair
TypeBlend
Dividend Yield1.64%

Risk Assessment

Beta-0.20
Volatility21.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.